We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Teva Sees Limited Competition in Biosimilar Market

News   Jan 16, 2012

 
Teva Sees Limited Competition in Biosimilar Market
 
 
Advertisement
 

RELATED ARTICLES

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

News

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.

READ MORE

Survey Highlights the Effects of COVID-19 Pandemic on Life Scientists

News

Jan Korbel and Oliver Stegle, both group leaders at EMBL Heidelberg, have performed a survey of fellow life scientists in Germany, Spain, the UK, Italy, France, Canada, Turkey, and the USA to learn how the current crisis, with partial or complete institutional shutdowns, is affecting their work.

READ MORE

Are Coronavirus Vaccines and Therapeutics Waiting in the Wings?

News

An overview of published scientific information on potential therapeutic agents and vaccines for the new coronavirus, highlighted that to date, more than 500 patents have been issued for vaccines and therapeutic agents that could help prevent or treat coronavirus infections.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE